LOTUS PHARM CO LTD FDA Approval ANDA 216915

ANDA 216915

LOTUS PHARM CO LTD

FDA Drug Application

Application #216915

Application Sponsors

ANDA 216915LOTUS PHARM CO LTD

Marketing Status

None (Tentative Approval)001
None (Tentative Approval)002

FDA Submissions

UNKNOWN; ORIG1TA2023-01-12STANDARD

Submissions Property Types

ORIG1Null31

CDER Filings

LOTUS PHARM CO LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 216915
            [companyName] => LOTUS PHARM CO LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"NINTEDANIB","activeIngredients":"NINTEDANIB","strength":"100MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"},{"drugName":"NINTEDANIB","activeIngredients":"NINTEDANIB","strength":"150MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"01\/12\/2023","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2023-01-12
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.